H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue

Jade Biosciences Inc. (NASDAQ:JBIO) is one of the overlooked growth stocks to buy. On January 7, H.C. Wainwright initiated coverage of Jade Biosciences with a Buy rating and $25 price target. The firm identified the company as being strategically positioned to secure a leadership role within the autoimmune market. The firm projects that JADE101, specifically for the treatment of immunoglobulin A nephropathy, could generate $926 million in risk-adjusted revenue by 2037.

In Q3 2025, Jade Biosciences Inc. (NASDAQ:JBIO) highlighted major progress for its lead candidate, JADE101, and the introduction of a new development program, JADE201. Backed by a successful $135 million private placement completed in October, Jade extended its cash runway into H1 2028, positioning itself to hit several upcoming clinical milestones.

Jade Biosciences is currently advancing JADE101, a selective anti-APRIL monoclonal antibody designed for patients with IgA nephropathy. The company presented preclinical data showing that JADE101 was well-tolerated in non-human primates, establishing a no-observed-adverse-effect level that supports its current Phase 1 trial. The drug demonstrated reversible reductions in serum immunoglobulins without broad immune suppression.

Jade Biosciences Inc. (NASDAQ:JBIO) operates as a biotech company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.

While we acknowledge the potential of JBIO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.